Devyser Genomic Laboratories receives Accreditation from College of American Pathologists
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation...
Many testing strategies have been developed in laboratories across the world. Optimal strategies generally include what might be termed “level 1” and “level 2” testing. Until the recent application of next generation sequencing (NGS), no single-pass assay has been capable of routinely screening for all published CFTR mutations. Multi-level testing has therefore been a cost-effective strategy to maximize mutation detection in populations where a small number of common mutations account for a significant proportion of the overall mutation spectrum.
This whitepaper is authored by Stewart Payne, Consultant Clinical Scientist at UK National Health Service and Head of Molecular Genetics in the North West Thames Regional Genetics since 1995. Stewart’s laboratory was one of few in the UK offering CFTR whole gene analysis by Sanger sequencing and has recently translated whole gene analysis to next generation sequencing.
Many testing strategies have been developed in laboratories across the world. Optimal strategies generally include what might be termed “level 1” and “level 2” testing. Until the recent application of next generation sequencing (NGS), no single-pass assay has been capable of routinely screening for all published CFTR mutations. Multi-level testing has therefore been a cost-effective strategy to maximize mutation detection in populations where a small number of common mutations account for a significant proportion of the overall mutation spectrum.
This whitepaper is authored by Stewart Payne, Consultant Clinical Scientist at UK National Health Service and Head of Molecular Genetics in the North West Thames Regional Genetics since 1995. Stewart’s laboratory was one of few in the UK offering CFTR whole gene analysis by Sanger sequencing and has recently translated whole gene analysis to next generation sequencing.
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation...
Read More
Devyser a leading provider of genetic testing solutions, has been awarded a significant tender for...
Read More
Read More
Read More